Island Pharmaceuticals (ASX:ILA) Raises A$9M as FDA Confirms Galidesivir Pathway: Is This Small-Cap Biotech a Buy?

Island Pharmaceuticals jumps after FDA backs galidesivir pathway Island Pharmaceuticals (ASX: ILA) surged as much as 23% to an intraday high of A$0.48 on Wednesday before settling at A$0.42, after…

ByUjjwal Maheshwari

08

Jan 2026

Biotech Stocks

Island Pharmaceuticals (ASX:ILA) Surges 12% on US Patent Win: Speculative Buy or Too Risky?

Island Pharmaceuticals Secures US Patent for Galidesivir Island Pharmaceuticals (ASX: ILA) jumped 12 per cent this week after announcing it secured a US patent for galidesivir, its antiviral drug designed…

ByUjjwal Maheshwari

27

Aug 2025

Biotech Stocks Healthcare Stocks Small Caps Stocks

Galidesivir has made Island Pharmaceuticals the ultimate ‘America First’ play for ASX investors!

Think of 'America First' ASX stocks and Island Pharmaceuticals (ASX:ILA) typically hasn't come to mind, but its acquisition of Galidesivir should put it firmly in the list. You cannot question…

ByNick Sundich

18

Aug 2025

Healthcare Stocks International Stocks

ASX Health Care Stocks Under Trump: Who’ll Win and Who’ll Lose?

What does the next few years hold for ASX Health Care Stocks Under Trump? There's no doubt that the health care sector is bearing a greater brunt than any other…

ByNick Sundich

05

Dec 2024

Healthcare Stocks Life Sciences

Island Pharmaceuticals’ PROTECT clinical trial is delivering the goods!

Investors were evidently pleased with the results out of Island Pharmaceuticals' PROTECT clinical trial...at least if the company's more than doubling in the past two months is anything to go…

ByNick Sundich

15

Oct 2024

Healthcare Stocks

Island Pharmaceuticals (ASX:ILA): One of the rare ASX biotechs fighting mosquito diseases – and it’s in Phase 2

Island Pharmaceuticals (ASX:ILA) is one of the few (if not the only) ASX-listed Biotechs that is focused on mosquito diseases, primarily Dengue fever. Mosquito diseases, such as Dengue, are expensive…

ByNick Sundich

13

Sep 2024

Healthcare Stocks Mid Cap Stocks News Penny Stocks Small Caps Stocks

The 2024 Pitt Street Research Life Sciences Conference is coming up! And you’re invited!

The Pitt Street Research Life Sciences Conference is happening on September 19, 2024! The Life Sciences sector in Australia and New Zealand continues to mature in 2024. In spite…

ByNick Sundich

Island Pharmaceuticals (ASX:ILA) Raises A$9M as FDA Confirms Galidesivir Pathway: Is This Small-Cap Biotech a Buy?

Island Pharmaceuticals (ASX:ILA) Surges 12% on US Patent Win: Speculative Buy or Too Risky?

Galidesivir has made Island Pharmaceuticals the ultimate ‘America First’ play for ASX investors!

ASX Health Care Stocks Under Trump: Who’ll Win and Who’ll Lose?

Island Pharmaceuticals’ PROTECT clinical trial is delivering the goods!

Island Pharmaceuticals (ASX:ILA): One of the rare ASX biotechs fighting mosquito diseases – and it’s in Phase 2

The 2024 Pitt Street Research Life Sciences Conference is coming up! And you’re invited!

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Add Your Heading Text Here